184 related articles for article (PubMed ID: 35053296)
1. T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma.
Fisicaro P; Boni C
Cells; 2022 Jan; 11(2):. PubMed ID: 35053296
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches.
Kalathil SG; Thanavala Y
Cells; 2021 May; 10(6):. PubMed ID: 34071188
[TBL] [Abstract][Full Text] [Related]
3. Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy.
Liu P; Chen L; Zhang H
J Immunol Res; 2018; 2018():1206737. PubMed ID: 30255103
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
[TBL] [Abstract][Full Text] [Related]
5. NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.
Sun C; Sun H; Zhang C; Tian Z
Cell Mol Immunol; 2015 May; 12(3):292-302. PubMed ID: 25308752
[TBL] [Abstract][Full Text] [Related]
6. The interactions between major immune effector cells and Hepatocellular Carcinoma: A systematic review.
Schoenberg MB; Li X; Li X; Han Y; Börner N; Koch D; Guba MO; Werner J; Bazhin AV
Int Immunopharmacol; 2021 Dec; 101(Pt A):108220. PubMed ID: 34673334
[TBL] [Abstract][Full Text] [Related]
7. Immune responses in hepatocellular carcinoma.
Korangy F; Höchst B; Manns MP; Greten TF
Dig Dis; 2010; 28(1):150-4. PubMed ID: 20460904
[TBL] [Abstract][Full Text] [Related]
8. Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.
Bozward AG; Warricker F; Oo YH; Khakoo SI
Front Immunol; 2021; 12():643310. PubMed ID: 33995362
[TBL] [Abstract][Full Text] [Related]
9. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
[TBL] [Abstract][Full Text] [Related]
10. New generation cancer therapy: right direction for sure with some uncertainty.
Ueno Y
Hepatol Int; 2019 Jan; 13(1):22-24. PubMed ID: 30406337
[No Abstract] [Full Text] [Related]
11. Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients.
Qian L; Wang N; Tian H; Jin H; Zhao H; Niu C; He H; Ge T; Han W; Hu J; Li D; Han F; Xu J; Ding X; Chen J; Li W; Cui J
J Immunol Res; 2016; 2016():6837241. PubMed ID: 27069936
[TBL] [Abstract][Full Text] [Related]
12. Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies.
Healy K; Pasetto A; Sobkowiak MJ; Soon CF; Cornberg M; Aleman S; Sällberg Chen M
Cells; 2020 Jun; 9(6):. PubMed ID: 32560123
[TBL] [Abstract][Full Text] [Related]
13. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.
Sung PS; Jang JW
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463262
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management.
Shirabe K; Motomura T; Muto J; Toshima T; Matono R; Mano Y; Takeishi K; Ijichi H; Harada N; Uchiyama H; Yoshizumi T; Taketomi A; Maehara Y
Int J Clin Oncol; 2010 Dec; 15(6):552-8. PubMed ID: 20963618
[TBL] [Abstract][Full Text] [Related]
15. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma.
Cui Z; Li H; Liu C; Wang J; Chen C; Hu S; Zhao X; Li G
Aging (Albany NY); 2024 Apr; 16(7):6550-6565. PubMed ID: 38604154
[TBL] [Abstract][Full Text] [Related]
16. [Perspectives on immunotherapy for hepatocellular carcinoma].
Schmidt N; Büttner N; Thimme R
Dtsch Med Wochenschr; 2013 Apr; 138(14):740-4. PubMed ID: 23533044
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles.
Wu M; Mei F; Liu W; Jiang J
Biomed Pharmacother; 2020 Jan; 121():109637. PubMed ID: 31810126
[TBL] [Abstract][Full Text] [Related]
18. Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.
Ruf B; Heinrich B; Greten TF
Cell Mol Immunol; 2021 Jan; 18(1):112-127. PubMed ID: 33235387
[TBL] [Abstract][Full Text] [Related]
19. Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma.
Kamiya T; Chang YH; Campana D
Cancer Immunol Res; 2016 Jul; 4(7):574-81. PubMed ID: 27197065
[TBL] [Abstract][Full Text] [Related]
20. Recurrent hepatocellular carcinoma cells with stem cell-like properties: possible targets for immunotherapy.
Xu X; Xing B; Hu M; Xu Z; Xie Y; Dai G; Gu J; Wang Y; Zhang Z
Cytotherapy; 2010 Apr; 12(2):190-200. PubMed ID: 19929456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
